Grants and Contributions:
Title:
Lead Optimization Studies
Agreement Number:
937340
Agreement Value:
$90,000.00
Agreement Date:
Nov 1, 2019 - Mar 31, 2020
Description:
The project will advance our novel series of GPR119 agonists in a series of Lead optimization studies with the goal of identifying a lead candidate for T2DM and other metabolic disorders.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V6C 3P1
Reference Number:
172-2019-2020-Q3-937340
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
801099599
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The total amended value is -50,000 dollars.
Amendment Date
Mar 11, 2020
Recipient's Legal Name:
Pramana Pharmaceuticals Inc.
Federal Riding Name:
Vancouver Centre
Federal Riding Number:
59034
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410
Amendments: